Form D · Biotechnology
Theradaptive, Inc.
Frederick, MD · CIK 0002148461
Offering snapshot reported Aug 4, 2026 · SEC filing
- Reported sold
- $36.2M Offering amount: $77.9M
- Investors reported
- 65 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 21, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 4, 2026 | Initial | $36,156,177 | No comparison | 65 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-593094
Source: Form D, filed Aug 4, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Luis Alvarez | Director, Executive |
| Jeffrey Dunn | Director |
| David Harrington | Director |
| Ted A. Meyers | Director |
| George Shanine | Director |
| David Stewart | Director, Executive |
| Patrick Zhang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7495 New Horizon Way, Suite 240
Frederick, MD, 21703
Phone: (617) 454-4050
Frederick, MD, 21703
Phone: (617) 454-4050